GL1X · GenesisL1 explorer

MolNFT v1 · #185625 · protein

Toxoplasma gondii PRP4K kinase domain (L715F) bound to altiratinib

7Q4A · Non-specific SERINE/THREONINE protein kinase: “Toxoplasma gondii PRP4K kinase domain (L715F) bound to altiratinib”. X-ray diffraction, 2 ligands (A9I, SCN), 6 pockets (best druggability 0.75). MolNFT v1 #185625 on GenesisL1: 3D…

PDB
7Q4A
Type
protein
Length
681 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-specific SERINE/THREONINE protein kinase
EC
2.7.11.1
UniProt
S7UT92
Ligands
A9I, SCN
Pockets
6 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANon-specific SERINE/THREONINE protein kinase (EC 2.7.11.1)protein33540% helix, 16% strandS7UT92
BNon-specific SERINE/THREONINE protein kinase (EC 2.7.11.1)protein34640% helix, 16% strandS7UT92

Ligands and binding sites

  • A9I · Altiratinib · ligand · 2 copies · chains A, B
  • SCN · Thiocyanate ion · ion · chains B
  • GOL · Glycerol · additive · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14380.750.8447A9I
23360.740.8544A9I
33050.610.7834empty
43610.590.7632empty
5730.350.7721empty

Interfaces

1 interface between chains.

  • A–B · 610 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 7Q4A · Toxoplasma gondii PRP4K kinase domain (L715F) bound to altiratinib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.